Skip to main content
. 2021 Aug 4;2(2):106–114. doi: 10.1016/j.bpsgos.2021.07.009

Table 3.

Dominant Model z-Score Meta-analysis

Reference Country Duration N Average Age, Years Scales Assessed Measure OR (95% CI)a z Score Stouffer’s z p Value
Cheon et al., 2009 (16) Korea 8 weeks 114 9 ADHD-RS-IV, CGI-I ≥50% ADHD-RS-IV reduction 2.26 (0.67–7.62) 1.32 3.03 .002
Huang et al., 2018 (25) Taiwan 4 weeks 59 11 SNAP-IV ≥50% SNAP-IV reduction 3.45 (0.36–32.90) 1.08
Unal et al., 2016 (11) Turkey 4–6 weeks 108 10 CGI-S, GAS, CPT, TMT-A/B, CPRS, CTRS ≥50% improvement on any CPRS/CTRS subscale and GAS ≥60 and ≥2 points improvement in CGI-S 0.89 (0.40–2.00) −0.28
Polanczyk et al., 2007 (14) Brazil 1 and 3 months 106 10 SNAP-IV Δ SNAP-IV 2.89 (1.40–5.97) 2.88
da Silva et al., 2008 (15) Brazil 4 weeks 59 12 SNAP-IV Δ SNAP-IV 3.50 (1.27–9.66) 2.41
Contini et al., 2011 (17) Brazil 4 weeks 165 35 SNAP-IV, CGI-S ≥30% SNAP-IV reduction and CGI-S and CGI-S ≤2 1.07 (0.44–2.58) 0.00

Stouffer’s z score for improved outcomes in G-allele carriers relative to CC subjects.

ADHD-RS-IV, ADHD Rating Scale-IV; CGI-I, Clinical Global Impressions–Improvement; CGI-S, CGI–Severity; CI, confidence interval; CPRS, Conners’ Parent Rating Scale; CTRS, Conners’ Teacher Rating Scale; GAS, Global Assessment of Functioning Scale; OR, odds ratio; SNAP-IV, Swanson, Nolan, and Pelham Version-IV Scale; TMT, Trail Making Test.

a

Odds of improved outcome among carriers of rs1800544.